Images

Filter by

Figure 1 Increasing Focus Beyond Ejection Fraction in Heart Failure Management
Figure 1: Increasing Focus Beyond Ejection Fraction in Heart Failure Management
Table 2 Clinical Settings of Patients versus Proposed Solutions to Challenges
Table 2: Clinical Settings of Patients versus Proposed Solutions to Challenges
Table 1 Clinical Settings of Patients versus Challenges
Table 1: Clinical Settings of Patients versus Challenges
Table 2 Characteristics of the Studies Investigating Safety and Efficacy of Heart Failure Medications in Cardiac Amyloidosis
Table 2: Characteristics of the Studies Investigating Safety and Efficacy of Heart Failure Medications in Cardiac Amyloidosis
Table 1 Recommendations for Drugs for Heart Failure in Cardiac Amyloidosis
Table 1: Recommendations for Drugs for Heart Failure in Cardiac Amyloidosis
Figure 1 Heart Failure Treatment in Cardiac Amyloidosis
Figure 1: Heart Failure Treatment in Cardiac Amyloidosis
Figure 2 Forest Plot Illustrating Significantly Independent in Hospital AllCause Mortality Predictors in the HK Cohort
Figure 2: Forest Plot Illustrating Significantly Independent in-Hospital AllCause Mortality Predictors in the HK Cohort
Table 2 Medication Use on Admission and Discharge in HK and Non HK Cohorts
Table 2: Medication Use on Admission and Discharge in HK and Non-HK Cohorts
Table 1 Demographics Comorbidities and In hospital Outcome During ADHF Admission in HK and Non HK Cohorts
Table 1: Demographics, Comorbidities and In-hospital Outcome During ADHF Admission in HK and Non-HK Cohorts
Figure 1 Flow Chart of the Study Population
Figure 1: Flow Chart of the Study Population
Figure 3 In Vivo Lusitropic Effect of Compound 8 in Streptozotocin Rats by Echocardiography after a Single or Repeated Oral Dosing
Figure 3: In Vivo Lusitropic Effect of Compound 8 in Streptozotocin Rats (by Echocardiography) after a Single or Repeated Oral Dosing
Figure 2 Modulation of the Na K Pump and SERCA2a by Istaroxime and its Derivatives
Figure 2: Modulation of the Na+ /K+ Pump and SERCA2a by Istaroxime and its Derivatives